Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan · Delayed Price · Currency is JPY 3,855.00
-55.00 (-1.41%)
Aug 4, 2026, 10:00 AM JST
Towa Pharmaceutical Market Cap
Towa Pharmaceutical has a market cap or net worth of 192.48 billion as of August 3, 2026. Its market cap has increased by 16.20% in one year.
Market Cap
192.48B
Enterprise Value
376.13B
Revenue
273.71B
Ranking
n/a
PE Ratio
36.66
Stock Price
3,855.00
ChartMarket Cap Chart
Since January 20, 1995, Towa Pharmaceutical's market cap has increased from 104.94B to 192.48B, an increase of 83.42%. That is a compound annual growth rate of 1.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 192.48B | 7.42% |
| Dec 30, 2025 | 179.19B | 8.50% |
| Dec 30, 2024 | 165.16B | 42.67% |
| Dec 29, 2023 | 115.76B | 10.36% |
| Dec 30, 2022 | 104.89B | -25.58% |
| Dec 30, 2021 | 140.95B | 49.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sumitomo Pharma | 569.94B |
| Tsumura & Co. | 282.53B |
| Nippon Shinyaku | 230.71B |
| Sawai Group Holdings | 186.68B |
| Kissei Pharmaceutical | 159.80B |
| Kaken Pharmaceutical | 144.66B |
| Mochida Pharmaceutical | 112.64B |
| Zeria Pharmaceutical | 91.20B |